Hilo Raises $19 Million to Launch US Blood Pressure System
Updated
Updated · Fitt Insider · Jul 21
Hilo Raises $19 Million to Launch US Blood Pressure System
2 articles · Updated · Fitt Insider · Jul 21
Summary
$19 million in new Series B extension funding will help Swiss wearable company Hilo bring its BP+ blood pressure system to US consumers.
Hilo Core combines a screenless wearable, an FDA-cleared connected cuff and an app, using optical sensors to contextualize up to 35 daily readings with heart rate and sleep data.
The company says it already has 200,000 global users and backing from eight clinical studies, building on the $42 million it raised last year as it aims to become a regulated medical platform.
The US launch targets a large unmet need: about half of American adults have hypertension, only a quarter have it under control, and roughly a sixth do not know they have it.
Hilo enters a crowded field where rivals including Withings, Garmin, WHOOP, Apple, Oura and Samsung are testing how far wearable blood-pressure features can go before crossing from wellness into medical-device regulation.
As tech giants enter health, can Hilo's monitor compete against Apple and Samsung's established wearable ecosystems?
Is continuous blood pressure data the future of health, or will accuracy issues keep traditional cuffs the gold standard?
Hilo Band’s Landmark FDA Clearance: How Cuffless Blood Pressure Monitoring and $42M Series B Funding Are Transforming Hypertension Care Globally
Overview
Hilo, formerly known as Aktiia, has made a major breakthrough by entering the U.S. market with the Hilo Band, the first cuffless blood pressure companion cleared by the FDA for over-the-counter use. This achievement confirms the device’s safety and user-friendly design, opening a new market and setting a new standard for medical-grade wearables. Hilo’s vision and scientific rigor are highlighted by this regulatory success, which is seen as a pivotal moment for cardiovascular health technology. The company’s expansion is fueled by strong funding and a commitment to making blood pressure monitoring more accessible and effective for everyone.